Post op Pain in Hip SurgeriesPhase 4NCT07631416
Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia
A Phase 4 study testing 0.25% bupivacaine in people with Post op Pain in Hip Surgeries, run by Sohag University at 1 site in Egypt.
Trial summary
Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia The aim of this study is to compare the analgesic efficacy of lumbar ElectroSpine Plane Block and Fascia Iliaca Plane Block in patients undergoing hip surgery under spinal anesthesia. Read more about this study
- Who is it for?
- Ages 18 to 90 yearsHealthy volunteers can take part
- Conditions the study is for
- Post op Pain in Hip Surgeries
- What is being tested?
- 0.25% bupivacaine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteEgypt
- Study dates
- 20 May 2026to 28 Nov 2026
- Phase
- Phase 4
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- • Age between ≥ 18 years
- Both sexes.
- American Society of Anesthesiologists (ASA) Physical Status I-III
- Undergoing elective unilateral hip surgeries under spinal anesthesia
- Patients with body mass index (BMI) < 35 kg/m²
Who cannot join
- • Patient refusal
- Known allergy to local anesthetics
- Infection at the site of block
- Coagulopathy or bleeding disorders
- Cognitive impairment affecting pain assessment
- Chronic opioid use
- Neuromuscular disorders as patients with stroke.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia The aim of this study is to compare the analgesic efficacy of lumbar ElectroSpine Plane Block and Fascia Iliaca Plane Block in patients undergoing hip surgery under spinal anesthesia.
Read the detailed description
Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia The aim of this study is to compare the analgesic efficacy of lumbar ElectroSpine Plane Block and Fascia Iliaca Plane Block in patients undergoing hip surgery under spinal anesthesia.
Primary outcome:
- Follow up postoprative pain.
Secondary outcome:
- Requirment of analgesic drugs either (opoid or non opoid) postoprative.
- Conditions
- Post op Pain in Hip Surgeries
- Being tested
- 0.25% bupivacaine
- Keywords
- post op pain in hip surgeries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
0.25% bupivacaineDrug
Also called 0.25% isobaric bupivacaine
Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia
| Study group | Role | What they receive |
|---|---|---|
| group A lumber electrospine plane block | Active comparator | 20ml of 0.25% bupivacaine will be injected into the interfascial plane between the erector spinae muscle and L5 transverse process. Receives: Drug: 0.25% bupivacaine |
| group B fascia iliaca plane block | Active comparator | a total of 20 mL of 0.25% bupivacaine will be slowly injected in fascia iliaca Receives: Drug: 0.25% bupivacaine |
What is being measured
The primary outcome is the main question the study is designed to answer.
follow up postoperative pain by Visual Analogue Scale (VAS)score
follow up postoperative pain every 2hours
Measured: follow up postoperative pain in 24 hours
Secondary outcomes (1)
Requirment of analgesic drugs either (opoid or non opoid) postoprative by Viscual Analogue Scale (VAS) Score
Requirment of analgesic drugs either (opoid or non opoid) postoprative.every 2hours
Measured: Requirment of analgesic drugs either (opoid or non opoid) postoprative. in 24hours
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jun 2026
- Study start20 May 2026 (estimated)
- Primary completion28 Nov 2026 (estimated)
- Study completion28 Nov 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Post op Pain in Hip SurgeriesStudies of the same condition, open and under way.
- More trials run by Sohag UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Model description
- compare fascia iliaca plane block versus lumbar Erectospinae plane block in hip replacement as Postoperative Analgesia arm 1 fascia iliaca plane block arm 2 lumber electrospine plane block A standardized analgesic regimen will be prescribed in the postoperative period. Patients will be observed at 0, 2, 4, 6, 12,18 and 24 hours for postoperative VAS scores. All patients will receive paracetamol 1 gm every 6 h as routine analgesia. If VAS is more than 3 intravenous morphine 3mg will be administered as rescue analgesia
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Sohag University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hadeer Ali Darder, Sohag University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07631416
- Sponsor's protocol ID
- Erector Spinae Plane Block
- Status last verified
- Jun 2026
- First submitted
- 9 Mar 2026
- Last updated
- 8 Jun 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia
Study at a glance
From the registry record, last updated by the sponsor on 8 Jun 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia
- ClinicalTrials.gov ID
- NCT07631416
- Acronym / sponsor ID
- Erector Spinae Plane Block
- Conditions
- Post op Pain in Hip Surgeries
- Keywords
- post op pain in hip surgeries
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- Sohag UniversityUniversity, hospital or other
- Study start
- 20 May 2026 (estimated)
- Primary completion
- 28 Nov 2026 (estimated)
- Study completion
- 28 Nov 2026 (estimated)
- First posted
- 8 Jun 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia The aim of this study is to compare the analgesic efficacy of lumbar ElectroSpine Plane Block and Fascia Iliaca Plane Block in patients undergoing hip surgery under spinal anesthesia.
Detailed description
Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia The aim of this study is to compare the analgesic efficacy of lumbar ElectroSpine Plane Block and Fascia Iliaca Plane Block in patients undergoing hip surgery under spinal anesthesia.
Primary outcome:
- Follow up postoprative pain.
Secondary outcome:
- Requirment of analgesic drugs either (opoid or non opoid) postoprative.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
- Model description
- compare fascia iliaca plane block versus lumbar Erectospinae plane block in hip replacement as Postoperative Analgesia arm 1 fascia iliaca plane block arm 2 lumber electrospine plane block A standardized analgesic regimen will be prescribed in the postoperative period. Patients will be observed at 0, 2, 4, 6, 12,18 and 24 hours for postoperative VAS scores. All patients will receive paracetamol 1 gm every 6 h as routine analgesia. If VAS is more than 3 intravenous morphine 3mg will be administered as rescue analgesia
| Arm | Type | Receives |
|---|---|---|
| group A lumber electrospine plane block | Active comparator | Drug: 0.25% bupivacaine20ml of 0.25% bupivacaine will be injected into the interfascial plane between the erector spinae muscle and L5 transverse process. |
| group B fascia iliaca plane block | Active comparator | Drug: 0.25% bupivacainea total of 20 mL of 0.25% bupivacaine will be slowly injected in fascia iliaca |
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- • Age between ≥ 18 years
Key exclusion criteria (7 listed)
- • Patient refusal
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| 0.25% bupivacaineAlso: 0.25% isobaric bupivacaineLumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia | Drug | group A lumber electrospine plane block, group B fascia iliaca plane block |
Primary outcome
follow up postoperative pain by Visual Analogue Scale (VAS)score
Time frame: follow up postoperative pain in 24 hours
follow up postoperative pain every 2hours
1 secondary outcome
Requirment of analgesic drugs either (opoid or non opoid) postoprative by Viscual Analogue Scale (VAS) Score
Time frame: Requirment of analgesic drugs either (opoid or non opoid) postoprative. in 24hours
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jun 2026.
- Individual participant dataSharing planned: No. Lumbar Erector Spinae Plane Block Versus Fascia Iliaca Plane Block in Hip Surgeries as Postoperative Analgesia
Related trials for Post op Pain in Hip Surgeries
Not yet recruiting
Dexmedetomidine vs. Tramadol With Ropivacaine in Ultrasound-Guided PENG Block for Hip Surgery
Postoperative Pain
Not yet recruitingPhase 3
Safety and Efficacy of Dexamethasone Versus Dexmedetomidine as Adjuvants in PENG Block in Hip Surgeries for Postoperative Pain Management
Postoperative Pain, Total Hip Arthroplasty (THA)
Not yet recruiting
PENG vs. Femoral Nerve Block for Pain Control in Hip Surgery
Pain, Postoperative
Not yet recruiting
Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blocks for Hip Surgery Analgesia
Postoperative Pain, Hip Osteoarthritis
Recruiting
Sacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia
Hip Arthroplasty, Hip Fracture Surgeries
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing 0.25% bupivacaine in people with Post op Pain in Hip Surgeries, run by Sohag University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 8 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact hadeer ali, resident (01115813875 ext. 01115813875, doradoctora46@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
follow up postoperative pain by Visual Analogue Scale (VAS)score (time frame: follow up postoperative pain in 24 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2026.